Replies to post #379879 on Anavex Life Sciences Corp (AVXL)

[plexrec]

LaFlaca--good find--this from Nov.22,2016 PR----from Dr. Perry---"George Perry, PhD, Dean and Professor at the University of Texas at San Antonio and Editor-in Chief of the Journal of Alzheimer’s Disease, commented, “Although this is an open label study with 32 patients, I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug. It is quite plausible that complex CNS diseases like Alzheimer’s may require a comprehensive approach, including restoration of cellular homeostasis.” Expecting same or better results when we get upcoming TLD--prior to Ctad 2022 !!!! WGT !